Emerging Companies

Brian Goldstein, David Brown, Karen Copenhaver

Larry Naughton, Bill Asher

Capital Markets Leader

Lawyers have represented blue chip underwriters and investment bankers, including:

 

Bank of America Merrill Lynch
Canaccord Genuity
Deutsche Bank
JP Morgan Chase
Morgan Stanley
Needham & Co.
SG Cowen Securities
Stifel Nicolaus Weisel
UBS Securities
William Blair

 

Blue Chip Clients

Lawyers have represented blue chip clients, including:

 

Astellas Pharma
Bayer
Cedar Point Communications
Citrix Systems
Dana Farber
Eisai
General Electric
Harvard
Hewlett-Packard
L-1 Identity Solutions
Mass General Hospital Matritech
Memorial Sloan-Kettering
MIT
Open Text
Pegasystems
Raytheon
SeaChange International Sierra Pacific
Southwall Technologies Stanford
Teradyne
Vertex Pharmaceuticals
Wyeth/Pfizer

Leader in Venture Capital

Facilitating introductions and highly knowledgeable in equity financings through representation of preeminent venture capital firms, including:

Advent International
Ampersand Ventures
Argo Global Capital
Ascent Venture Partners
Atlas Venture Fund
Battery Ventures
BCE Capital
Bessemer Venture Partners BioVentures Investors
Boston Millennia Partners
Cardinal Health Partners
Celtic House
Essex Woodlands
Fairhaven Capital
Fidelity Ventures
Flagship Ventures
Flybridge Venture Capital
General Catalyst
Globespan Capital Partners
GrandBanks Capital
Greylock Partners
Highland Capital Partners
IDG Ventures
Kodiak Venture Partners
MedEquity
North Bridge
Oxford Bioscience
Polaris Ventures
Prism Venture Partners
Summit Partners
VenGrowth

 

emerging companies

"well regarded for its financing and transactional work in the technology and healthcare sectors"

Chambers USA

Emerging Companies Specialty 

Representing emerging technology and life sciences companies in their entire life cycle from start-up to public company to M&A.  Lawyers have organized several thousand emerging companies.

Transaction Powerhouse 

High-level transaction experience to assist emerging companies in all capital needs through all stages of growth:

Venture financings with proceeds over $5.6 billion
Public company securities offerings with proceeds over $20 billion
Mergers and acquisitions with value over $60 billion
(since 2000)

Bench Strength

70 lawyers representing technology and life sciences companies.  Lawyers throughout practice areas consistently receive national recognition for excellence.

Full Range of IP Services

Full range of services, including strategic IP counseling; patent prosecution; trademark prosecution; copyright protection; and trade secrets and unfair competition counseling.  One of first major Boston firms to establish patent group.  Sophisticated IP due diligence for investors and acquirers.  Decades of litigation experience in IP disputes.

World-Class Licensing Capability

Among most experienced and knowledgeable licensing lawyers in US in all areas including open source.

Experts in Industry Partnerships 

Lawyers have negotiated key strategic partnerships, licenses, joint ventures, distributorships and commercial transactions with industry leaders, including:

Alcatel

Intel 

Baxter Healthcare

Monsanto 

Becton, Dickinson 

Nortel 

Cisco 

Oracle 

Comcast 

Pfizer 

Dow Chemicals 

Pharmacia 

IBM 

 

National/International Reach 

Technology and life sciences company transactions across US and abroad.  Preeminent US – Canada cross-border practice.

National Recognition 

Nationally recognized:

  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital deals negotiated and closed in 2012 (Private Equity Analyst)
  • Ranked nationally among the top law firms in the US for Venture Capital and Emerging Companies (The Legal 500, guide to the preeminent law firms in US)
  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital funds worked on for general partners and limited partners that closed in 2012 (Private Equity Analyst)
  • “Buyout Deal of the Year” award for 2005: Choate represented private equity seller (Buyouts Magazine)
 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline